Trials in line for potential asthma drugRPL554, a potential drug for providing relief to patients suffering from asthma is undergoing human trials in the near future after it successfully cleared trials on more than 60 people in the year 2008 at the Centre for Human Drug Research (CHDR) in the Netherlands.

The drug is believed to offer a crucial insight to medical practitioners across the globe to treat asthmatic patients. This potential drug for asthma is expected to reach the market in the next 3-5 years after successful completion of initial trials for safety and efficacy.

From News-Medical.Net:

Current treatments for asthma and hay fever sufferers are beta-agonists, which open up the airways, and inhaled steroids, which dampen down the inflammation that causes irritation - they are either taken together or singly.

But they have serious side effects, including possible harm to the cardiovascular system and the ’shakes’ reported by many patients from excess use.

Experts say little progress has been made recently with alternative, effective and practical treatment options for a wide range of people with asthma and hay fever and by combining anti-inflammatory properties and the ability to overcome airway narrowing in a single long-lasting dose via the nose, RPL554 could offer real hope of a significant breakthrough.

Some practitioners are of the view that this drug will help them to draw new and improved treatment plans for treating their asthmatic patients.


Tags: , , , , ,

Posted in Steroid Cycles, Steroids and Anabolic Steroids, buy steroids, steroid nation